MicroRNA therapeutics: towards a new era for the management of cancer and other diseases

Untitled work

Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714 · see citing works

Inflammation and cancer

Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111 · see citing works

The blockade of immune checkpoints in cancer immunotherapy

Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838 · see citing works

The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14

Lee, R. C., Feinbaum, R. L., & Ambros, V. (1993) · Cell · doi:10.1016/0092-8674(93)90529-y · Cited by 12,948 · see citing works

Predicting effective microRNA target sites in mammalian mRNAs

Agarwal, V., Bell, G. W., Nam, J.-W., & Bartel, D. P. (2015) · eLife · doi:10.7554/elife.05005 · Cited by 7,318 · see citing works

starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein–RNA interaction networks from large-scale CLIP-Seq data

Li, J.-H., Liu, S., Zhou, H., Qu, L., & Yang, J.-H. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt1248 · Cited by 5,587 · see citing works

Regulation of microRNA biogenesis

Ha, M., & Kim, V. N. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3838 · Cited by 5,462 · see citing works

The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans

Reinhart, B. J., Slack, F. J., Basson, M., Pasquinelli, A. E., Bettinger, J. C., Rougvie, A. E., Horvitz, H. R., & Ruvkun, G. (2000) · Nature · doi:10.1038/35002607 · Cited by 4,989 · see citing works

Non-coding RNAs in human disease

Esteller, M. (2011) · Nature Reviews Genetics · doi:10.1038/nrg3074 · Cited by 4,825 · see citing works

Silencing of microRNAs in vivo with ‘antagomirs’

Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949 · see citing works

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

Gregory, P. A., Bert, A. G., Paterson, E. L., Barry, S. C., Tsykin, A., Farshid, G., Vadas, M. A., Khew‐Goodall, Y., & Goodall, G. J. (2008) · Nature Cell Biology · doi:10.1038/ncb1722 · Cited by 3,852 · see citing works

RAS Is Regulated by the let-7 MicroRNA Family

Johnson, S., Großhans, H., Shingara, J., Byrom, M., JARVIS, R., Cheng, A., Labourier, E., Reinert, K. L., Brown, D., & Slack, F. J. (2005) · Cell · doi:10.1016/j.cell.2005.01.014 · Cited by 3,662 · see citing works

c-Myc-regulated microRNAs modulate E2F1 expression

O’Donnell, K. A., Wentzel, E. A., Zeller, K. I., Dang, C. V., & Mendell, J. T. (2005) · Nature · doi:10.1038/nature03677 · Cited by 2,812 · see citing works

Tumour invasion and metastasis initiated by microRNA-10b in breast cancer

Ma, L., Teruya-Feldstein, J., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06174 · Cited by 2,605 · see citing works

Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA

Pasquinelli, A. E., Reinhart, B. J., Slack, F. J., Martindale, M. Q., Kuroda, M. I., Maller, B., Hayward, D. C., Ball, E. E., Degnan, B. M., Müller, P., et al. (2000) · Nature · doi:10.1038/35040556 · Cited by 2,568 · see citing works

Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles

Davis, M. E., Zuckerman, J. E., Choi, C. H. J., Seligson, D. B., Tolcher, A. W., Alabi, C. A., Yen, Y., Heidel, J. D., & Ribas, A. (2010) · Nature · doi:10.1038/nature08956 · Cited by 2,508 · see citing works

Modulation of Hepatitis C Virus RNA Abundance by a Liver-Specific MicroRNA

Jopling, C. L., Yi, M., Lancaster, A. M., Lemon, S. M., & Sarnow, P. (2005) · Science · doi:10.1126/science.1113329 · Cited by 2,503 · see citing works

Regulatory networks defining EMT during cancer initiation and progression

Craene, B. D., & Berx, G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3447 · Cited by 2,487 · see citing works

MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts

Thum, T., Gross, C., Fiedler, J., Fischer, T., Kissler, S., Bussen, M., Galuppo, P., Just, S., Rottbauer, W., Frantz, S., et al. (2008) · Nature · doi:10.1038/nature07511 · Cited by 2,349 · see citing works

The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2

Park, S.-M., Gaur, A. B., Lengyel, E., & Peter, M. E. (2008) · Genes & Development · doi:10.1101/gad.1640608 · Cited by 2,272 · see citing works

Hypoxia in cancer: significance and impact on clinical outcome

Vaupel, P., & Mayer, A. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9055-1 · Cited by 2,240 · see citing works

Treatment of HCV Infection by Targeting MicroRNA

Janssen, H. L. A., Reesink, H. W., Lawitz, E., Zeuzem, S., Rodriguez‐Torres, M., Patel, K., van der Meer, A. J., Patick, A. K., Chen, A. P., Zhou, Y., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1209026 · Cited by 2,206 · see citing works

MicroRNA biogenesis pathways in cancer

Lin, S., & Gregory, R. I. (2015) · Nature reviews. Cancer · doi:10.1038/nrc3932 · Cited by 2,117 · see citing works

miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting

Esau, C., Davis, S., Murray, S. F., Yu, X. X., Pandey, S. K., Pear, M., Watts, L., Booten, S. L., Graham, M., McKay, R., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.005 · Cited by 2,082 · see citing works

Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis

Chang, T.-C., Wentzel, E. A., Kent, O. A., Ramachandran, K., Mullendore, M., Lee, K. H., Feldmann, G., Yamakuchi, M., Ferlito, M., Lowenstein, C. J., et al. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.05.010 · Cited by 2,010 · see citing works

let-7 Regulates Self Renewal and Tumorigenicity of Breast Cancer Cells

Yu, F., Yao, H., Zhu, P., Zhang, X., Pan, Q., Gong, C., Huang, Y., Hu, X., Su, F., Lieberman, J., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.054 · Cited by 1,906 · see citing works

MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer

Asangani, I. A., Rasheed, S. A. K., Nikolova, D. A., Leupold, J. H., Colburn, N. H., Post, S., & Allgayer, H. (2008) · Oncogene · doi:10.1038/sj.onc.1210856 · Cited by 1,882 · see citing works

miRTarBase 2016: updates to the experimentally validated miRNA-target interactions database

Chou, C., Chang, N.-W., Shrestha, S., Hsu, S., Lin, Y., Lee, W.-H., Yang, C.-D., Hong, H.-C., Wei, T., Tu, S.-J., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1258 · Cited by 1,829 · see citing works

MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review

Iorio, M. V., & Croce, C. M. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201100209 · Cited by 1,738 · see citing works

A reciprocal repression between ZEB1 and members of the miR‐200 family promotes EMT and invasion in cancer cells

Burk, U., Schubert, J., Wellner, U. F., Schmalhofer, O., Vincan, E., Spaderna, S., & Brabletz, T. (2008) · EMBO Reports · doi:10.1038/embor.2008.74 · Cited by 1,722 · see citing works

Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model

Kota, J., Chivukula, R. R., O’Donnell, K. A., Wentzel, E. A., Montgomery, C. L., Hwang, H., Chang, T.-C., Vivekanandan, P., Torbenson, M. S., Clark, K. R., et al. (2009) · Cell · doi:10.1016/j.cell.2009.04.021 · Cited by 1,711 · see citing works

The miR-200 Family Inhibits Epithelial-Mesenchymal Transition and Cancer Cell Migration by Direct Targeting of E-cadherin Transcriptional Repressors ZEB1 and ZEB2

Korpal, M., Lee, E. S., Hu, G., & Kang, Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.c800074200 · Cited by 1,642 · see citing works

LNA-mediated microRNA silencing in non-human primates

Elmén, J., Lindow, M., Schütz, S., Lawrence, M., Petri, A., Obad, S., Lindholm, M., Hedtjärn, M., Hansen, H. F., Berger, U., et al. (2008) · Nature · doi:10.1038/nature06783 · Cited by 1,589 · see citing works

miR-145 and miR-143 regulate smooth muscle cell fate and plasticity

Cordes, K. R., Sheehy, N. T., White, M. P., Berry, E. C., Morton, S. U., Muth, A. N., Lee, T.-H., Miano, J. M., Ivey, K. N., & Srivastava, D. (2009) · Nature · doi:10.1038/nature08195 · Cited by 1,585 · see citing works

The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44

Liu, C., Kelnar, K., Liu, B., Chen, X., Calhoun‐Davis, T., Li, H., Patrawala, L., Yan, H., Jeter, C. R., Honorio, S., et al. (2011) · Nature Medicine · doi:10.1038/nm.2284 · Cited by 1,401 · see citing works

An Epigenetic Switch Involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 Links Inflammation to Cell Transformation

Iliopoulos, D., Hirsch, H. A., & Struhl, K. (2009) · Cell · doi:10.1016/j.cell.2009.10.014 · Cited by 1,374 · see citing works

Transcriptional Activation of miR-34a Contributes to p53-Mediated Apoptosis

Raver-Shapira, N., Marciano, E., Meiri, E., Spector, Y., Rosenfeld, N., Moskovits, N. B.-C., Bentwich, Z., & Oren, M. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.05.017 · Cited by 1,352 · see citing works

The let-7 family of microRNAs

Roush, S. F., & Slack, F. J. (2008) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.07.007 · Cited by 1,332 · see citing works

MiR-33 Contributes to the Regulation of Cholesterol Homeostasis

Rayner, K. J., Suárez, Y., Dávalos, A., Parathath, S., Fitzgerald, M. L., Tamehiro, N., Fisher, E. A., Moore, K. J., & Fernández-Hernando, C. (2010) · Science · doi:10.1126/science.1189862 · Cited by 1,260 · see citing works

The <i>let-7</i> MicroRNA Represses Cell Proliferation Pathways in Human Cells

Johnson, C. D., Esquela-Kerscher, A., Stefani, G., Byrom, M., Kelnar, K., Ovcharenko, D., Wilson, M., Wang, X., Shelton, J., Shingara, J., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1083 · Cited by 1,224 · see citing works

Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas

Cancer Genome Atlas Research Network, Campbell, J. D., Alexandrov, A., Kim, J., Wala, J., Berger, A. H., Pedamallu, C. S., Shukla, S. A., Guo, G., Brooks, A. N., et al. (2016) · Nature Genetics · doi:10.1038/ng.3564 · Cited by 1,200 · see citing works

Dendrimer biocompatibility and toxicity

Duncan, R., & Izzo, L. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.019 · Cited by 1,153 · see citing works

MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis

Yan, L., Huang, X.-F., Shao, Q., Huang, M., Deng, L., Wu, Q., Zeng, Y.-X., & Shao, J. (2008) · RNA · doi:10.1261/rna.1034808 · Cited by 1,142 · see citing works

Programmed Cell Death 4 (PDCD4) Is an Important Functional Target of the MicroRNA miR-21 in Breast Cancer Cells

Frankel, L. B., Christoffersen, N. R., Jacobsen, A., Lindow, M., Krogh, A., & Lund, A. H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707224200 · Cited by 1,141 · see citing works

Multivalent <i>N</i> -Acetylgalactosamine-Conjugated siRNA Localizes in Hepatocytes and Elicits Robust RNAi-Mediated Gene Silencing

Nair, J. K., Willoughby, J. L. S., Chan, A., Charisse, K., Alam, M. R., Wang, Q., Hoekstra, M., Kandasamy, P., Kel’in, A. V., Milstein, S., et al. (2014) · Journal of the American Chemical Society · doi:10.1021/ja505986a · Cited by 1,141 · see citing works

MicroRNA Expression Patterns to Differentiate Pancreatic Adenocarcinoma From Normal Pancreas and Chronic Pancreatitis

Bloomston, M., Frankel, W. L., Petrocca, F., Volinia, S., Alder, H., Hagan, J. P., Liu, C.-G., Bhatt, D., Taccioli, C., & Croce, C. M. (2007) · JAMA · doi:10.1001/jama.297.17.1901 · Cited by 1,141 · see citing works

A MicroRNA Signature of Hypoxia

Kulshreshtha, R., Ferracin, M., Wojcik, S. E., Garzon, R., Alder, H., Agosto-Perez, F. J., Davuluri, R., Liu, C.-G., Croce, C. M., Negrini, M., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01395-06 · Cited by 1,055 · see citing works

Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster

Dews, M., Homayouni, A., Yu, D., Murphy, D. A., Sevignani, C., Wentzel, E. A., Furth, E. E., Lee, W. M., Enders, G. H., Mendell, J. T., et al. (2006) · Nature Genetics · doi:10.1038/ng1855 · Cited by 1,049 · see citing works

Functional screening identifies miRNAs inducing cardiac regeneration

Eulalio, A., Mano, M., Ferro, M. D., Zentilin, L., Sinagra, G., Zacchigna, S., & Giacca, M. (2012) · Nature · doi:10.1038/nature11739 · Cited by 1,029 · see citing works

Therapeutic targeting of microRNAs: current status and future challenges

Li, Z., & Rana, T. M. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4359 · Cited by 1,028 · see citing works

MicroRNAs 103 and 107 regulate insulin sensitivity

Trajkovski, M., Hausser, J., Soutschek, J., Bhat, B., Akin, A., Zavolan, M., Heim, M. H., & Stoffel, M. (2011) · Nature · doi:10.1038/nature10112 · Cited by 1,000 · see citing works

miR‐21: a small multi‐faceted RNA

Krichevsky, A. M., & Gabriely, G. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00556.x · Cited by 987 · see citing works

OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma

Medina, P. P., Nolde, M., & Slack, F. J. (2010) · Nature · doi:10.1038/nature09284 · Cited by 971 · see citing works

Differential Regulation of microRNAs by p53 Revealed by Massively Parallel Sequencing: miR-34a is a p53 Target That Induces Apoptosis and G1-arrest

Tarasov, V., Jung, P., Verdoodt, B., Lodygin, D., Epanchintsev, A., Menssen, A., Meister, G., & Hermeking, H. (2007) · Cell Cycle · doi:10.4161/cc.6.13.4436 · Cited by 922 · see citing works

MicroRNA-210 Modulates Endothelial Cell Response to Hypoxia and Inhibits the Receptor Tyrosine Kinase Ligand Ephrin-A3

Fasanaro, P., D'Alessandra, Y., Di Stefano, V., Melchionna, R., Romani, S., Pompilio, G., Capogrossi, M. C., & Martelli, F. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800731200 · Cited by 912 · see citing works

The DLEU2/miR-15a/16-1 Cluster Controls B Cell Proliferation and Its Deletion Leads to Chronic Lymphocytic Leukemia

Klein, U., Lia, M., Crespo, M., Siegel, R., Shen, Q. “., Mo, T., Ambesi‐Impiombato, A., Califano, A., Migliazza, A., Bhagat, G., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.11.019 · Cited by 851 · see citing works

STAT3 Activation of miR-21 and miR-181b-1 via PTEN and CYLD Are Part of the Epigenetic Switch Linking Inflammation to Cancer

Iliopoulos, D., Jaeger, S. A., Hirsch, H. A., Bulyk, M. L., & Struhl, K. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.07.023 · Cited by 830 · see citing works

Inositol phosphatase SHIP1 is a primary target of miR-155

O'Connell, R. M., Chaudhuri, A. A., Rao, D. S., & Baltimore, D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902636106 · Cited by 826 · see citing works

MicroRNA silencing for cancer therapy targeted to the tumour microenvironment

Cheng, C. J., Bahal, R., Babar, I., Pincus, Z., Barrera, F. N., Liu, C. S., Svoronos, A. A., Braddock, D. T., Glazer, P. M., Engelman, D. M., et al. (2014) · Nature · doi:10.1038/nature13905 · Cited by 824 · see citing works

Regulation of the p27Kip1 tumor suppressor by miR‐221 and miR‐222 promotes cancer cell proliferation

le Sage, C., Nagel, R., Egan, D. A., Schrier, M., Mesman, E. M., Mangiola, A., Anile, C., Maira, G., Mercatelli, N., Ciafrè, S. A., et al. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601790 · Cited by 816 · see citing works

MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis

Tsai, W.-C., Hsu, S., Hsu, C.-S., Lai, T., Chen, S.-J., Shen, R., Huang, Y., Chen, H., Lee, C.-H., Tsai, T., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63455 · Cited by 815 · see citing works

The miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease

Mogilyansky, E., & Rigoutsos, I. (2013) · Cell Death &amp; Differentiation · doi:10.1038/cdd.2013.125 · Cited by 810 · see citing works

MiR-15a and miR-16-1 cluster functions in human leukemia

Calin, G. A., Cimmino, A., Fabbri, M., Ferracin, M., Wojcik, S. E., Shimizu, M., Taccioli, C., Zanesi, N. A. O., Garzon, R., Aqeilan, R. I., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800121105 · Cited by 808 · see citing works

MicroRNA Expression, Survival, and Response to Interferon in Liver Cancer

Ji, J., Shi, J., Budhu, A., Yu, Z., Forgues, M., Roessler, S. K., Ambs, S., Chen, Y., Meltzer, P. S., Croce, C. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901282 · Cited by 801 · see citing works

Biodegradable poly(lactic acid) polymers

Kulkarni, R. K., Moore, E. G., Hegyeli, A. F., & Leonard, F. (1971) · Journal of Biomedical Materials Research · doi:10.1002/jbm.820050305 · Cited by 798 · see citing works

Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver

Hsu, S., Wang, B., Kota, J., Yu, J., Costinean, S., Kutay, H., Yu, L., Bai, S., Perle, K. L., Chivukula, R. R., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63539 · Cited by 776 · see citing works

Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model

Ma, L., Reinhardt, F., Pan, E., Soutschek, J., Bhat, B., Marcusson, E. G., Teruya‐Feldstein, J., Bell, G. W., & Weinberg, R. A. (2010) · Nature Biotechnology · doi:10.1038/nbt.1618 · Cited by 773 · see citing works

IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis

Rokavec, M., Öner, M. G., Li, H., Jackstadt, R., Jiang, L., Lodygin, D., Kaller, M., Horst, D., Ziegler, P. K., Schwitalla, S., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci73531 · Cited by 753 · see citing works

miR-34 – a microRNA replacement therapy is headed to the clinic

Bader, A. (2012) · Front. Gene. · doi:10.3389/fgene.2012.00120 · Cited by 728 · see citing works

Dicer, Drosha, and Outcomes in Patients with Ovarian Cancer

Merritt, W. M., Lin, Y. G., Han, L. Y., Kamat, A. A., Spannuth, W. A., Schmandt, R. E., Urbauer, D. L., Pennacchio, L. A., Cheng, J., Nick, A. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0803785 · Cited by 710 · see citing works

Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides

Rayner, K. J., Esau, C. C., Hussain, F. N., McDaniel, A. L., Marshall, S. M., van Gils, J. M., Ray, T. D., Sheedy, F. J., Goedeke, L., Liu, X., et al. (2011) · Nature · doi:10.1038/nature10486 · Cited by 706 · see citing works

miR-221 overexpression contributes to liver tumorigenesis

Pineau, P., Volinia, S., McJunkin, K., Marchio, A., Battiston, C., Terris, B., Mazzaferro, V., Lowe, S. W., Croce, C. M., & Dejean, A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907904107 · Cited by 698 · see citing works

Lin-28 interaction with the Let-7 precursor loop mediates regulated microRNA processing

Newman, M. A., Thomson, J. M., & Hammond, S. M. (2008) · RNA · doi:10.1261/rna.1155108 · Cited by 691 · see citing works

miRNA Deregulation in Cancer Cells and the Tumor Microenvironment

Rupaimoole, R., Călin, G. A., Lopez‐Berestein, G., & Sood, A. K. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0893 · Cited by 691 · see citing works

PDL1 Regulation by p53 via miR-34

Cortez, M. A., Ivan, C., Valdecanas, D., Wang, X., Peltier, H. J., Ye, Y., Araujo, L., Carbone, D. P., Shilo, K., Giri, D. K., et al. (2016) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djv303 · Cited by 683 · see citing works

<i>DICER1</i> Mutations in Familial Pleuropulmonary Blastoma

Hill, D. A., Ivanovich, J., Priest, J. R., Gurnett, C. A., Dehner, L. P., Desruisseau, D., Jarzembowski, J. A., Wikenheiser-Brokamp, K. A., Suarez, B. K., Whelan, A. J., et al. (2009) · Science · doi:10.1126/science.1174334 · Cited by 682 · see citing works

Development of a Lung Cancer Therapeutic Based on the Tumor Suppressor MicroRNA-34

Wiggins, J. F., Ruffino, L., Kelnar, K., Omotola, M., Patrawala, L., Brown, D., & Bader, A. G. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0655 · Cited by 679 · see citing works

Therapeutic EphA2 Gene Targeting In vivo Using Neutral Liposomal Small Interfering RNA Delivery

Landen, C. N., Chávez‐Reyes, A., Bucana, C. D., Schmandt, R. E., Deavers, M. T., Lopez‐Berestein, G., & Sood, A. K. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0530 · Cited by 674 · see citing works

miR-155 gene: A typical multifunctional microRNA

Faraoni, I., Antonetti, F. R., Cardone, J., & Bonmassar, E. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.02.013 · Cited by 672 · see citing works

miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling

Dávalos, A., Goedeke, L., Smibert, P., Ramírez, C. M., Warrier, N. P., Andreo, U., Cirera-Salinas, D., Rayner, K., Suresh, U., Pastor-Pareja, J. C., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102281108 · Cited by 670 · see citing works

Systemic Delivery of Tumor Suppressor microRNA Mimics Using a Neutral Lipid Emulsion Inhibits Lung Tumors in Mice

Trang, P., Wiggins, J. F., Daige, C. L., Cho, C., Omotola, M., Brown, D., Weidhaas, J. B., Bader, A. G., & Slack, F. J. (2011) · Molecular Therapy · doi:10.1038/mt.2011.48 · Cited by 669 · see citing works

Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver

Elmén, J., Lindow, M., Silahtaroglu, A., Bak, M., Christensen, M., Lind-Thomsen, A., Hedtjärn, M., Hansen, J. B., Hansen, H. F., Straarup, E. M., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm1113 · Cited by 669 · see citing works

A MicroRNA Targeting Dicer for Metastasis Control

Martello, G., Rosato, A., Ferrari, F., Manfrin, A., Cordenonsi, M., Dupont, S., Enzo, E., Guzzardo, V., Rondina, M. B., Spruce, T., et al. (2010) · Cell · doi:10.1016/j.cell.2010.05.017 · Cited by 668 · see citing works

MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injuryPreprint

Xin, M., Small, E. M., Sutherland, L. B., Qi, X., McAnally, J., Plato, C. F., Richardson, J. A., Bassel‐Duby, R., & Olson, E. N. (2009) · Genes & Development · doi:10.1101/gad.1842409 · Cited by 648 · see citing works

Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster

Boettger, T., Beetz, N., Sawa Kostin, D., Schneider, J., Krüger, M., Hein, L., & Braun, T. W. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38864 · Cited by 644 · see citing works

Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin

Kovalchuk, O., Filkowski, J. N., Meservy, J. L., Ilnytskyy, Y., Tryndyak, V., Chekhun, V. F., & Pogribny, I. P. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0021 · Cited by 636 · see citing works

Modulation of K-Ras-Dependent Lung Tumorigenesis by MicroRNA-21

Hatley, M. E., Patrick, D. M., Garcia, M. R., Richardson, J. A., Bassel-Duby, R., van Rooij, E., & Olson, E. N. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.08.013 · Cited by 626 · see citing works

Development of microRNA therapeutics is coming of age

van Rooij, E., & Kauppinen, S. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201100899 · Cited by 625 · see citing works

MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles

van Rooij, E., & Olson, E. N. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3864 · Cited by 620 · see citing works

Reduced expression of Dicer associated with poor prognosis in lung cancer patients

Karube, Y., Tanaka, H., Osada, H., Tomida, S., Tatematsu, Y., Yanagisawa, K., Yatabe, Y., Takamizawa, J., Miyoshi, S., Mitsudomi, T., et al. (2005) · Cancer Science · doi:10.1111/j.1349-7006.2005.00015.x · Cited by 601 · see citing works

Therapeutic Inhibition of miR-208a Improves Cardiac Function and Survival During Heart Failure

Montgomery, R. L., Hullinger, T. G., Semus, H. M., Dickinson, B., Seto, A. G., Lynch, J. M., Stack, C., Latimer, P. A., Olson, E. N., & van Rooij, E. (2011) · Circulation · doi:10.1161/circulationaha.111.030932 · Cited by 600 · see citing works

MicroRNA-21 Promotes Fibrosis of the Kidney by Silencing Metabolic Pathways

Chau, B. N., Xin, C., Hartner, J. C., Ren, S., Castaño, A. P., Linn, G. R., Li, J., Tran, P. T., Kaimal, V., Huang, X., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003205 · Cited by 589 · see citing works

Dicer Ablation Affects Antibody Diversity and Cell Survival in the B Lymphocyte Lineage

Koralov, S. B., Muljo, S. A., Galler, G. R., Krek, A., Chakraborty, T., Kanellopoulou, C., Jensen, K., Cobb, B. S., Merkenschlager, M., Rajewsky, N., et al. (2008) · Cell · doi:10.1016/j.cell.2008.02.020 · Cited by 575 · see citing works

An autocrine TGF-β/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition

Gregory, P. A., Bracken, C. P., Smith, E., Bert, A. G., Wright, J. A., Roslan, S., Morris, M. J., Belle, L., Farshid, G., Lim, Y., et al. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-02-0103 · Cited by 552 · see citing works

Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development

Gironella, M., Seux, M., Xie, M.-J., Cano, C. E., Tomasini, R., Gommeaux, J., Garcia, S., Nowak, J., Yeung, M. L., Jeang, K., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703942104 · Cited by 548 · see citing works

MicroRNA‐29, a key regulator of collagen expression in systemic sclerosis

Maurer, B., Stańczyk, J., Jüngel, A., Akhmetshina, A., Trenkmann, M., Brock, M., Kowal‐Bielecka, O., Gay, R. E., Michel, B. A., Distler, J. H. W., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27443 · Cited by 536 · see citing works

Inhibition of miR-15 Protects Against Cardiac Ischemic Injury

Hullinger, T. G., Montgomery, R. L., Seto, A. G., Dickinson, B., Semus, H. M., Lynch, J. M., Dalby, C. M., Robinson, K., Stack, C., Latimer, P. A., et al. (2011) · Circulation Research · doi:10.1161/circresaha.111.244442 · Cited by 502 · see citing works

Mir-34: A New Weapon Against Cancer?

Misso, G., Martino, M. T. D., Rosa, G. D., Farooqı, A. A., Lombardi, A., Campani, V., Zarone, M. R., Gullà, A., Tagliaferri, P., Tassone, P., et al. (2014) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2014.47 · Cited by 497 · see citing works

Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma

Babar, I., Cheng, C. J., Booth, C. J., Liang, X., Weidhaas, J. B., Saltzman, W. M., & Slack, F. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201516109 · Cited by 496 · see citing works

Nonviral delivery of synthetic siRNAs in vivo

Akhtar, S., & Benter, I. F. (2007) · Journal of Clinical Investigation · doi:10.1172/jci33494 · Cited by 464 · see citing works

Recurrent SomaticDICER1Mutations in Nonepithelial Ovarian Cancers

Heravi‐Moussavi, A., Anglesio, M. S., Cheng, S., Senz, J., Yang, W., Prentice, L., Fejes, A. P., Chow, C., Tone, A. A., Kalloger, S. E., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102903 · Cited by 462 · see citing works

The Human let-7a-3 Locus Contains an Epigenetically Regulated MicroRNA Gene with Oncogenic Function

Brueckner, B., Stresemann, C., Kuner, R., Mund, C., Musch, T., Meister, M. A., Sültmann, H., & Lyko, F. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4074 · Cited by 444 · see citing works

MicroRNA regulation of DNA repair gene expression in hypoxic stress

Crosby, M. E., Kulshreshtha, R., Ivan, M., & Glazer, P. M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2516 · Cited by 437 · see citing works

miR-21 Gene Expression Triggered by AP-1 Is Sustained through a Double-Negative Feedback Mechanism

Fujita, S., Ito, T., Mizutani, T., Minoguchi, S., Yamamichi, N., Sakurai, K., & Iba, H. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.03.015 · Cited by 432 · see citing works

Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer

Kong, W. W., He, L., Richards, E. J., Challa, S., Cx, X., Permuth‐Wey, J., Lancaster, J., Coppola, D., Sellers, T. A., Djeu, J. Y., et al. (2013) · Oncogene · doi:10.1038/onc.2012.636 · Cited by 422 · see citing works

miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity

Puisségur, M.-P., Mazure, N. M., Bertero, T., Pradelli, L. A., Grosso, S., Robbe-Sermesant, K., Maurin, T., Lebrigand, K., Cardinaud, B., Hofman, V., et al. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2010.119 · Cited by 422 · see citing works

TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs

Su, X., Chakravarti, D., Cho, M. S., Liu, L.-Z., Gi, Y. J., Lin, Y.-L., Leung, M. L., El‐Naggar, A. K., Creighton, C. J., Suraokar, M. B., et al. (2010) · Nature · doi:10.1038/nature09459 · Cited by 419 · see citing works

Tumour angiogenesis regulation by the miR-200 family

Pecot, C. V., Rupaimoole, R., Yang, D., Akbani, R., Ivan, C., Lu, C., Wu, S. Y., Han, H., Shah, M., Rodriguez‐Aguayo, C., et al. (2013) · Nature Communications · doi:10.1038/ncomms3427 · Cited by 400 · see citing works

MicroRNA replacement therapy for miR-145 and miR-33a is efficacious in a model of colon carcinoma.

Ibrahim, A., Weirauch, U., Thomas, M., Grünweller, A., Hartmann, R. K., & Aigner, A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4645 · Cited by 398 · see citing works

Integrated Analyses Identify a Master MicroRNA Regulatory Network for the Mesenchymal Subtype in Serous Ovarian Cancer

Yang, D., Sun, Y., Hu, L., Zheng, H., Ji, P., Pecot, C. V., Zhao, Y., Reynolds, S. M., Cheng, H., Rupaimoole, R., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2012.12.020 · Cited by 395 · see citing works

MicroRNA-1 Negatively Regulates Expression of the Hypertrophy-Associated Calmodulin and Mef2a Genes

Ikeda, S., He, A., Kong, S. W., Lü, J., Bejar, R. L., Bodyak, N. D., Lee, K., Ma, Q., Kang, P. M., Golub, T. R., et al. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01222-08 · Cited by 390 · see citing works

The role of the insulin-like growth factor-1 system in breast cancer

CHRISTOPOULOS, P. F., Msaouel, P., & Koutsilieris, M. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0291-7 · Cited by 377 · see citing works

MicroRNAs Reprogram Normal Fibroblasts into Cancer-Associated Fibroblasts in Ovarian Cancer

Mitra, A. K., Zillhardt, M., Hua, Y., Tiwari, P., Murmann, A. E., Peter, M. E., & Lengyel, E. R. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0206 · Cited by 371 · see citing works

Inhibiting MicroRNA-192 Ameliorates Renal Fibrosis in Diabetic Nephropathy

Putta, S., Lanting, L. L., Sun, G., Lawson, G. W., Kato, M. V., & Natarajan, R. D. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011050485 · Cited by 369 · see citing works

A Cardiac MicroRNA Governs Systemic Energy Homeostasis by Regulation of MED13

Grueter, C. E., van Rooij, E., Johnson, B. A., DeLeon, S. M., Sutherland, L. B., Qi, X., Gautron, L., Elmquist, J. K., Bassel‐Duby, R., & Olson, E. N. (2012) · Cell · doi:10.1016/j.cell.2012.03.029 · Cited by 365 · see citing works

EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2

Shen, J., Xia, W., Khotskaya, Y. B., Huo, L., Nakanishi, K., Lim, S., Du, Y., Wang, Y., Chang, W., Chen, C., et al. (2013) · Nature · doi:10.1038/nature12080 · Cited by 358 · see citing works

A Genetic Defect in Exportin-5 Traps Precursor MicroRNAs in the Nucleus of Cancer Cells

Melo, S. A., Moutinho, C., Ropero, S., Calin, G. A., Rossi, S., Spizzo, R., Fernández, A. F., Dávalos, V., Villanueva, A., Montoya, G., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.09.007 · Cited by 347 · see citing works

miR-155 : On the Crosstalk Between Inflammation and Cancer

Tili, E., Croce, C. M., & Michaille, J. (2009) · International Reviews of Immunology · doi:10.1080/08830180903093796 · Cited by 343 · see citing works

MicroRNA-21 in Cardiovascular Disease

Cheng, Y., & Zhang, C. (2010) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-010-9169-7 · Cited by 333 · see citing works

Hepatitis C Virus RNA Functionally Sequesters miR-122

Luna, J. M., Scheel, T. K. H., Danino, T., Shaw, K. S., Mele, A., Fak, J. J., Nishiuchi, E., Takacs, C. N., Catanese, M. T., de Jong, Y. P., et al. (2015) · Cell · doi:10.1016/j.cell.2015.02.025 · Cited by 332 · see citing works

MicroRNA-200b Regulates Vascular Endothelial Growth Factor–Mediated Alterations in Diabetic Retinopathy

Mcarthur, K., Feng, B., Wu, Y., Chen, S., & Chakrabarti, S. (2011) · Diabetes · doi:10.2337/db10-1557 · Cited by 329 · see citing works

MiR-34a inhibits proliferation and migration of breast cancer through down-regulation of Bcl-2 and SIRT1

Li, L., Yuan, L., Luo, J., Gao, J., Guo, J., & Xie, X. (2012) · Clinical and Experimental Medicine · doi:10.1007/s10238-012-0186-5 · Cited by 314 · see citing works

Tumor suppressor miR-34a targets PD-L1 and functions as a potential immunotherapeutic target in acute myeloid leukemia

Wang, X., Li, J., Dong, K., Fang, L., Long, M., Ouyang, Y., Wei, J., Chen, X., Weng, Y., He, T., et al. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.12.003 · Cited by 313 · see citing works

New Class of Polymers for the Delivery of Macromolecular Therapeutics

Gonzalez, H., Hwang, S., & Davis, M. E. (1999) · Bioconjugate Chemistry · doi:10.1021/bc990072j · Cited by 312 · see citing works

Bacterially Derived 400 nm Particles for Encapsulation and Cancer Cell Targeting of Chemotherapeutics

MacDiarmid, J. A., Amaro-Mugridge, N. B., Weiss, J., Phillips, L., Burn, A. L., Paulin, R. P., Haasdyk, J. E., Dickson, K.-A., Brahmbhatt, V. N., Pattison, S. T., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.03.012 · Cited by 307 · see citing works

Human Glioma Growth Is Controlled by MicroRNA-10b

Gabriely, G., Yi, M., Narayan, R. S., Niers, J. M., Wurdinger, T. D., Imitola, J., Ligon, K. L., Kesari, S., Esau, C., Stephens, R. M., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3568 · Cited by 301 · see citing works

A positive feedback between p53 and miR-34 miRNAs mediates tumor suppressionPreprint

Okada, N., Lin, C., Ribeiro, M. C., Biton, A., Lai, G., He, X., Bu, P., Vogel, H. S., Jablons, D. M., Keller, A., et al. (2014) · Genes & Development · doi:10.1101/gad.233585.113 · Cited by 297 · see citing works

Germline deletion of the miR-17∼92 cluster causes skeletal and growth defects in humans

de Pontual, L., Yao, E. S., Callier, P., Faivre, L. O., Drouin‐Garraud, V., Cariou, S., van Haeringen, A., Geneviève, D., Goldenberg, A., Oufadem, M., et al. (2011) · Nature Genetics · doi:10.1038/ng.915 · Cited by 295 · see citing works

Restitution of Tumor Suppressor MicroRNAs Using a Systemic Nanovector Inhibits Pancreatic Cancer Growth in Mice

Pramanik, D., Campbell, N. R., Karikari, C. A., Chivukula, R. R., Kent, O. A., Mendell, J. T., & Maitra, A. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0152 · Cited by 295 · see citing works

Pharmacokinetic Properties of 2′-O-(2-Methoxyethyl)-Modified Oligonucleotide Analogs in Rats

Geary, R. S., Watanabe, T. A., Truong, L., Freier, S., Lesnik, E. A., Sioufi, N. B., Sasmor, H. M., Manoharan, M., & Levin, A. A. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38831-7 · Cited by 289 · see citing works

The microRNA-200 family regulates pancreatic beta cell survival in type 2 diabetes

Belgardt, B., Ahmed, K., Spranger, M., Latreille, M., Denzler, R., Kondratiuk, N., von Meyenn, F., Villena, F. N., Herrmanns, K., Bosco, D., et al. (2015) · Nature Medicine · doi:10.1038/nm.3862 · Cited by 279 · see citing works

MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways

Keklikoglou, I., Körner, C., Schmidt, C., Zhang, J. D., Heckmann, D., Shavinskaya, A., Allgayer, H., Gückel, B., Fehm, T. N., Schneeweiß, A., et al. (2011) · Oncogene · doi:10.1038/onc.2011.571 · Cited by 273 · see citing works

PEG conjugated VEGF siRNA for anti-angiogenic gene therapy

Kim, S. H., Jeong, J. H., Lee, S. H., Kim, S. W., & Park, T. G. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.05.023 · Cited by 273 · see citing works

Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320

Bronisz, A., Godlewski, J. A., Wallace, J. A., Merchant, A. S., Nowicki, M. O., Mathsyaraja, H., Srinivasan, R., Trimboli, A. J., Martin, C. K., Li, F., et al. (2011) · Nature Cell Biology · doi:10.1038/ncb2396 · Cited by 270 · see citing works

MicroRNA-29c Is a Signature MicroRNA under High Glucose Conditions That Targets Sprouty Homolog 1, and Its in Vivo Knockdown Prevents Progression of Diabetic Nephropathy

Long, J., Wang, Y., Wang, W., Chang, B. H., & Danesh, F. R. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.194969 · Cited by 265 · see citing works

Chitosan-based siRNA delivery systems

Ragelle, H., Vandermeulen, G., & Préat, V. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.08.005 · Cited by 261 · see citing works

Translocation of molecules into cells by pH-dependent insertion of a transmembrane helix

Reshetnyak, Y. K., Andreev, O. A., Lehnert, U., & Engelman, D. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601463103 · Cited by 257 · see citing works

MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1

Sun, L., Yao, Y., Liu, B., Lin, Z., Lin, L., Yang, M., Zhang, W., Chen, W., Pan, C., Liu, Q., et al. (2011) · Oncogene · doi:10.1038/onc.2011.263 · Cited by 249 · see citing works

E-Cadherin Expression Is Regulated by miR-192/215 by a Mechanism That Is Independent of the Profibrotic Effects of Transforming Growth Factor-β

Wang, B., Herman‐Edelstein, M., Koh, P., Burns, W. C., Jandeleit-Dahm, K. A. M., Watson, A. M. D., Saleem, M. A., Goodall, G. J., Twigg, S. M., Cooper, M. E., et al. (2010) · Diabetes · doi:10.2337/db09-1736 · Cited by 244 · see citing works

Systemic delivery of siRNA with cationic lipid assisted PEG-PLA nanoparticles for cancer therapy

Yang, X., Dou, S., Sun, T., Mao, C., Wang, H., & Wang, J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.07.035 · Cited by 242 · see citing works

miRNA-34 Prevents Cancer Initiation and Progression in a Therapeutically Resistant K-ras and p53-Induced Mouse Model of Lung Adenocarcinoma

Kasinski, A. L., & Slack, F. J. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2001 · Cited by 242 · see citing works

The ATM Kinase Induces MicroRNA Biogenesis in the DNA Damage Response

Zhang, X., Wan, G., Berger, F. G., He, X., & Lu, X. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.01.020 · Cited by 239 · see citing works

MicroRNA mimicry blocks pulmonary fibrosis

Montgomery, R. L., Yu, G., Latimer, P. A., Stack, C., Robinson, K., Dalby, C. M., Kaminski, N., & van Rooij, E. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201303604 · Cited by 238 · see citing works

Down-regulation of Krüppel-like Factor-4 (KLF4) by MicroRNA-143/145 Is Critical for Modulation of Vascular Smooth Muscle Cell Phenotype by Transforming Growth Factor-β and Bone Morphogenetic Protein 4

Davis‐Dusenbery, B. N., Chan, M. C., Reno, K. E., Weisman, A. S., Layne, M. D., Lagna, G., & Hata, A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.236950 · Cited by 237 · see citing works

Somatic mutations in DROSHA and DICER1 impair microRNA biogenesis through distinct mechanisms in Wilms tumours

Rakheja, D., Chen, K. S.-M., Liu, Y., Shukla, A. A., Schmid, V., Chang, T.-C., Khokhar, S., Wickiser, J. E., Karandikar, N. J., Malter, J. S., et al. (2014) · Nature Communications · doi:10.1038/ncomms5802 · Cited by 234 · see citing works

In Vitro Antiviral Activity and Preclinical and Clinical Resistance Profile of Miravirsen, a Novel Anti-Hepatitis C Virus Therapeutic Targeting the Human Factor miR-122

Ottosen, S., Parsley, T. B., Yang, L., Zeh, K., van Doorn, L., van der Veer, E., Raney, A. K., Hodges, M. R., & Patick, A. K. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04220-14 · Cited by 231 · see citing works

Changes in MicroRNA Expression Contribute to Pancreatic β-Cell Dysfunction in Prediabetic NOD Mice

Roggli, E., Gattesco, S., Caille, D., Briet, C., Boîtard, C., Meda, P., & Regazzi, R. (2012) · Diabetes · doi:10.2337/db11-1086 · Cited by 227 · see citing works

Mutator activity induced by microRNA-155 ( miR-155 ) links inflammation and cancer

Tili, E., Michaille, J., Wernicke, D., Alder, H., Costinean, S., Volinia, S., & Croce, C. M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1101795108 · Cited by 227 · see citing works

Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER

van den Beucken, T., Koch, E., Chu, K., Rupaimoole, R., Prickaerts, P., Adriaens, M. E., Voncken, J. W., Harris, A. L., Buffa, F. M., Haider, S. A., et al. (2014) · Nature Communications · doi:10.1038/ncomms6203 · Cited by 226 · see citing works

let-7 regulates Dicer expression and constitutes a negative feedback loop

Tokumaru, S., Suzuki, M., Yamada, H., Nagino, M., & Takahashi, T. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn187 · Cited by 225 · see citing works

Nanomedicine based approaches for the delivery of siRNA in cancer

Özpolat, B., Sood, A. K., & Lopez‐Berestein, G. (2009) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2009.02191.x · Cited by 219 · see citing works

miR-221 Silencing Blocks Hepatocellular Carcinoma and Promotes Survival

Park, J. K., Kogure, T., Nuovo, G. J., Jiang, J., He, L., Kim, J. H., Phelps, M. A., Papenfuss, T. L., Croce, C. M., Patel, T. C., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1144 · Cited by 219 · see citing works

The let-7/LIN-41 Pathway Regulates Reprogramming to Human Induced Pluripotent Stem Cells by Controlling Expression of Prodifferentiation Genes

Worringer, K. A., Rand, T., Hayashi, Y., Sami, S., Takahashi, K., Tanabe, K., Narita, M., Srivastava, D., & Yamanaka, S. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.11.001 · Cited by 214 · see citing works

MicroRNA regulons in tumor microenvironment

Suzuki, H. I., Katsura, A., Matsuyama, H., & Miyazono, K. (2014) · Oncogene · doi:10.1038/onc.2014.254 · Cited by 208 · see citing works

Micro RNA s play a central role in molecular dysfunctions linking inflammation with cancer

Tili, E., Michaille, J., & Croce, C. M. (2013) · Immunological Reviews · doi:10.1111/imr.12050 · Cited by 207 · see citing works

Upregulated expression of miR-1/miR-206 in a rat model of myocardial infarction.

Shan, Z., Lin, Q., Fu, Y.-H., Deng, C.-Y., Zhou, Z.-L., Zhu, J.-N., Liu, X.-Y., Zhang, Y.-Y., Li, Y.-X., Lin, S.-G., et al. (2009) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2009.02.097 · Cited by 206 · see citing works

Therapeutic Delivery of miR-200c Enhances Radiosensitivity in Lung Cancer

Cortez, M. A., Valdecanas, D. R., Zhang, X., Zhan, Y., Bhardwaj, V., Călin, G. A., Komaki, R. K., Giri, D. K., Quini, C. C., Wolfe, T., et al. (2014) · Molecular Therapy · doi:10.1038/mt.2014.79 · Cited by 197 · see citing works

miR-CLIP capture of a miRNA targetome uncovers a lincRNA H19–miR-106a interaction

Imig, J., Brunschweiger, A., Brümmer, A., Guennewig, B., Mittal, N., Kishore, S., Tsikrika, P., Gerber, A. P., Zavolan, M., & Hall, J. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1713 · Cited by 188 · see citing works

Role of miR-15/16 in CLL

Pekarsky, Y., & Croce, C. M. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.87 · Cited by 186 · see citing works

Energetics of peptide (pHLIP) binding to and folding across a lipid bilayer membrane

Reshetnyak, Y. K., Andreev, O. A., Segala, M., Markin, V. S., & Engelman, D. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804746105 · Cited by 186 · see citing works

Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression

Rupaimoole, R., Wu, S. Y., Pradeep, S., Ivan, C., Pecot, C. V., Gharpure, K. M., Nagaraja, A. S., Armaiz-Peña, G. N., McGuire, M. H., Zand, B., et al. (2014) · Nature Communications · doi:10.1038/ncomms6202 · Cited by 181 · see citing works

MiR-21/Smad 7 signaling determines TGF-β1-induced CAF formation

Li, Q., Zhang, D., Wang, Y., Sun, P., Hou, X., Larner, J., Xiong, W., & Mi, J. (2013) · Scientific Reports · doi:10.1038/srep02038 · Cited by 176 · see citing works

Stromal Expression of miR-143/145 Promotes Neoangiogenesis in Lung Cancer Development

Dimitrova, N., Gocheva, V., Bhutkar, A. J., Resnick, R., Jong, R. M., Miller, K. M., Bendor, J., & Jacks, T. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0854 · Cited by 166 · see citing works

Therapeutic Synergy between microRNA and siRNA in Ovarian Cancer Treatment

Nishimura, M., Jung, E.-J., Shah, M., Lu, C., Spizzo, R., Shimizu, M., Han, H. D., Ivan, C., Rossi, S., Zhang, X., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0159 · Cited by 161 · see citing works

Down-regulation of the miRNA master regulators Drosha and Dicer is associated with specific subgroups of breast cancer

Dedes, K. J., Natrajan, R., Lambros, M. B. K., Geyer, F. C., López‐García, M. Á., Savage, K., Jones, R. L., & Reis-Filho, J. S. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.08.007 · Cited by 147 · see citing works

Long-term therapeutic silencing of miR-33 increases circulating triglyceride levels and hepatic lipid accumulation in mice

Goedeke, L., Salerno, A., Ramírez, C. M., Guo, L., Allen, R. M., Yin, X., Langley, S. R., Esau, C., Wanschel, A., Fisher, E. A., et al. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201404046 · Cited by 145 · see citing works

Combinatorial Action of MicroRNAs let-7 and miR-34 Effectively Synergizes with Erlotinib to Suppress Non-small Cell Lung Cancer Cell Proliferation

Stahlhut, C. E., & Slack, F. J. (2015) · Cell Cycle · doi:10.1080/15384101.2014.1003008 · Cited by 145 · see citing works

Augmentation of Response to Chemotherapy by microRNA-506 Through Regulation of RAD51 in Serous Ovarian Cancers

Liu, G., Yang, D., Rupaimoole, R., Pecot, C. V., Sun, Y., Mangala, L. S., Li, X., Ji, P., Cogdell, D. E., Hu, L., et al. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv108 · Cited by 125 · see citing works

MiR ‐506 suppresses proliferation and induces senescence by directly targeting the CDK4 /6– FOXM1 axis in ovarian cancer

Liu, G., Sun, Y., Ji, P., Li, X., Cogdell, D. E., Yang, D., Kerrigan, B. C. P., Ilya Shmulevich, C., Chen, K., Sood, A. K., et al. (2014) · The Journal of Pathology · doi:10.1002/path.4348 · Cited by 123 · see citing works

Downregulation of miR-210 expression inhibits proliferation, induces apoptosis and enhances radiosensitivity in hypoxic human hepatoma cells in vitro

Yang, W., Sun, T., Cao, J., Liu, F., Tian, Y., & Zhu, W. J. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.02.010 · Cited by 122 · see citing works

MicroRNA therapeutics: principles, expectations, and challenges

Rupaimoole, R., Han, H., Lopez‐Berestein, G., & Sood, A. K. (2011) · 癌症：英文版 · doi:10.5732/cjc.011.10186 · Cited by 114 · see citing works

High loading efficiency and tunable release of plasmid DNA encapsulated in submicron particles fabricated from PLGA conjugated with poly-L-lysine

Blum, J. S., & Saltzman, W. M. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.04.002 · Cited by 108 · see citing works

Loss of HOXD10 expression induced by upregulation of miR-10b accelerates the migration and invasion activities of ovarian cancer cells

Nakayama, I., Shibazaki, M., Yashima‐Abo, A., MIURA, F., Sugiyama, T., Masuda, T., & Maesawa, C. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1935 · Cited by 107 · see citing works

Hypoxia-upregulated microRNA-630 targets Dicer, leading to increased tumor progression

Rupaimoole, R., Ivan, C., Yang, D., Gharpure, K. M., Wu, S. Y., Pecot, C. V., Previs, R. A., Nagaraja, A. S., Armaiz-Peña, G. N., McGuire, M. H., et al. (2016) · Oncogene · doi:10.1038/onc.2015.492 · Cited by 96 · see citing works

Loss of Let-7 MicroRNA Upregulates IL-6 in Bone Marrow-Derived Mesenchymal Stem Cells Triggering a Reactive Stromal Response to Prostate Cancer

Sung, S.-Y., Liao, C., Wu, H.-P., Hsiao, W., Wu, I.-H., Jin-Pu, Yu, Lin, S.-H., & Hsieh, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071637 · Cited by 88 · see citing works

The two faces of miR-29

Ślusarz, A., & Pulakat, L. (2015) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000246 · Cited by 87 · see citing works

Dynamin 2 along with microRNA-199a reciprocally regulate hypoxia-inducible factors and ovarian cancer metastasis

Joshi, H. P., Subramanian, I. V., Schnettler, E. K., Ghosh, G., Rupaimoole, R., Evans, C., Saluja, M., Jing, Y., Ivan, C., Roy, S., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1317242111 · Cited by 87 · see citing works

Regulation of Hepatitis C Virus Genome Replication by Xrn1 and MicroRNA-122 Binding to Individual Sites in the 5′ Untranslated Region

Thibault, P. A., Huys, A., Amador‐Cañizares, Y., Gailius, J. E., Pinel, D. E., & Wilson, J. A. (2015) · Journal of Virology · doi:10.1128/jvi.03631-14 · Cited by 80 · see citing works

The microRNA-processing enzymes: Drosha and Dicer can predict prognosis of nasopharyngeal carcinoma

Guo, X., Liao, Q., Chen, P., Li, X., Xiong, W., Ma, J., Li, X., Luo, Z., Tang, H., Deng, M., et al. (2011) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-011-1058-1 · Cited by 80 · see citing works

Genotype-phenotype correlations in MYCN-related Feingold syndrome

Marcelis, C., Hol, F. A., Graham, G. E., Rieu, P. N. M. A., Kellermayer, R., Meijer, R. P. P., Lugtenberg, D., Scheffer, H., van Bokhoven, H., Brunner, H. G., et al. (2008) · Human Mutation · doi:10.1002/humu.20750 · Cited by 79 · see citing works

MicroRNAs in cardiovascular disease

Gurha, P. (2016) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000280 · Cited by 77 · see citing works

Combining miR-10b–Targeted Nanotherapy with Low-Dose Doxorubicin Elicits Durable Regressions of Metastatic Breast Cancer

Yoo, B., Kavishwar, A., Ross, A., Wang, P., Tabassum, D. P., Polyák, K., Barteneva, N., Petkova, V., Pantazopoulos, P., Tena, A., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0888 · Cited by 76 · see citing works

Defective DROSHA processing contributes to downregulation of MiR-15/-16 in chronic lymphocytic leukemia

Allegra, D., Bilan, V., Garding, A., Döhner, H., Stilgenbauer, S., Kuchenbauer, F., & Mertens, D. (2013) · Leukemia · doi:10.1038/leu.2013.246 · Cited by 71 · see citing works

c-Myc modulates microRNA processing via the transcriptional regulation of Drosha

Wang, X., Zhao, X., Gao, P., & Wu, M. (2013) · Scientific Reports · doi:10.1038/srep01942 · Cited by 70 · see citing works

Essential role of miRNAs in orchestrating the biology of the tumor microenvironment

Frediani, J., & Fabbri, M. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0525-3 · Cited by 64 · see citing works

Major regulators of microRNAs biogenesis Dicer and Drosha are down-regulated in endometrial cancer

Torres, A., Torres, K., Paszkowski, T., Jodłowska‐Jędrych, B., Radomański, T., Książek, A., & Maciejewski, R. (2011) · Tumor Biology · doi:10.1007/s13277-011-0179-0 · Cited by 61 · see citing works

The Duality of OncomiR Addiction in the Maintenance and Treatment of Cancer

Cheng, C. J., & Slack, F. J. (2012) · The Cancer Journal · doi:10.1097/ppo.0b013e318258b75b · Cited by 57 · see citing works

Nanocell targeting using engineered bispecific antibodies

Taylor, K., Howard, C. B., Jones, M. L., Sedliarou, I., MacDiarmid, J. A., Brahmbhatt, H. N., Munro, T. P., & Mahler, S. M. (2014) · mAbs · doi:10.4161/19420862.2014.985952 · Cited by 44 · see citing works

MesomiR 1: A Phase I study of TargomiRs in patients with refractory malignant pleural mesothelioma (MPM) and lung cancer (NSCLC)

van Zandwijk, N., Pavlakis, N., Kao, S., Clarke, S. J., Lee, A., Brahmbhatt, H. N., MacDiarmid, J. A., Pattison, S. T., Leslie, F., Huynh, Y., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv090.2 · Cited by 43 · see citing works

microRNA-10b is a prognostic biomarker for melanoma

Saldanha, G. S., Elshaw, S. R., Sachs, P., Alharbi, H., Shah, P., Jothi, A., & Pringle, J. H. (2016) · Modern Pathology · doi:10.1038/modpathol.2015.149 · Cited by 43 · see citing works

MRX34, a liposomal miR-34 mimic, in patients with advanced solid tumors: Final dose-escalation results from a first-in-human phase I trial of microRNA therapy.

Hong, D. S., Kang, Y., Brenner, A. J., Sachdev, J. C., Ejadi, S., Borad, M. J., Kim, T., Lim, H. Y., Park, K., Becerra, C. R., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.34.15_suppl.2508 · Cited by 34 · see citing works

Abstract C43: Safety, tolerability, and clinical activity of MRX34, the first-in-class liposomal miR-34 mimic, in patients with advanced solid tumors

Beg, M. S., Brenner, A. J., Sachdev, J. C., Ejadi, S., Borad, M. J., Kang, Y.-K., Lim, H. Y., Kim, T.-Y., Bader, A. G., Stoudemire, J., et al. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.targ-15-c43 · Cited by 21 · see citing works

Abstract 3976: Targeted delivery of a synthetic microRNA-based mimic as an approach to cancer therapy

Reid, G., Williams, M., Kirschner, M. B., Amaro-Mugridge, N. B., Weiss, J., Brahmbhatt, H. N., MacDiarmid, J. A., & van Zandwijk, N. (2015) · Cancer Research · doi:10.1158/1538-7445.am2015-3976 · Cited by 18 · see citing works

MicroRNA

Lu, T. X., & Rothenberg, M. E. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.08.034 · Cited by 2,425 · see citing works

Regulation of microRNA function in animals

Gebert, L. F. R., & MacRae, I. J. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0045-7 · Cited by 2,031 · see citing works

An overview of microRNAs: Biology, functions, therapeutics, and analysis methods

Saliminejad, K., Khorshid, H. R. K., Fard, S. S., & Ghaffari, S. H. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27486 · Cited by 2,047 · see citing works

Non-coding RNA networks in cancer

Anastasiadou, E., Jacob, L. S., & Slack, F. J. (2017) · Nature reviews. Cancer · doi:10.1038/nrc.2017.99 · Cited by 1,901 · see citing works

miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions

Chou, C., Shrestha, S., Yang, C.-D., Chang, N.-W., Lin, Y., Liao, K., Huang, W.-C., Sun, T.-H., Tu, S.-J., Lee, W.-H., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1067 · Cited by 1,813 · see citing works

The role of non-coding RNAs in oncology

Slack, F. J., & Chinnaiyan, A. M. (2019) · Cell · doi:10.1016/j.cell.2019.10.017 · Cited by 1,619 · see citing works

Epithelial Mesenchymal Transition in Tumor Metastasis

Mittal, V. (2018) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-020117-043854 · Cited by 1,528 · see citing works

Noncoding RNA therapeutics—Challenges and potential solutions

Winkle, M., El-Daly, S. M., Fabbri, M., & Calin, G. A. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00219-z · Cited by 1,551 · see citing works

The current state and future directions of RNAi-based therapeutics

Setten, R. L., Rossi, J. J., & Han, S.-P. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0017-4 · Cited by 1,443 · see citing works

Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation

Dhatchinamoorthy, K., Colbert, J. D., & Rock, K. L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.636568 · Cited by 1,077 · see citing works

RNA in cancer

Goodall, G. J., & Wickramasinghe, V. O. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-00306-0 · Cited by 1,070 · see citing works

Emerging concepts of miRNA therapeutics: from cells to clinic

Diener, C., Keller, A., & Meese, E. U. (2022) · Trends in Genetics · doi:10.1016/j.tig.2022.02.006 · Cited by 981 · see citing works

Non-coding RNAs in disease: from mechanisms to therapeutics

Németh, K., Bayraktar, R., Ferracin, M., & Călin, G. A. (2023) · Nature Reviews Genetics · doi:10.1038/s41576-023-00662-1 · Cited by 935 · see citing works

HMDD v3.0: a database for experimentally supported human microRNA–disease associations

Huang, Z., Shi, J., Gao, Y., Cui, C., Zhang, S., Li, J., Zhou, Y., & Cui, Q. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky1010 · Cited by 812 · see citing works

CRISPR/Cas9 therapeutics: progress and prospects

Li, T., Yang, Y., Qi, H., Cui, W., Zhang, L., Fu, X., He, X., Liu, M., Li, P., & Yu, T. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01309-7 · Cited by 770 · see citing works

Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs

Dilliard, S. A., & Siegwart, D. J. (2023) · Nature Reviews Materials · doi:10.1038/s41578-022-00529-7 · Cited by 707 · see citing works

RNA-based therapeutics: an overview and prospectus

Zhu, Y., Zhu, L., Wang, X., & Jin, H. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05075-2 · Cited by 658 · see citing works

Therapeutic Targeting of Long Non-Coding RNAs in Cancer

Arun, G., Diermeier, S. D., & Spector, D. L. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.01.001 · Cited by 612 · see citing works

MicroRNAs (miRNAs) and Long Non-Coding RNAs (lncRNAs) as New Tools for Cancer Therapy: First Steps from Bench to Bedside

Ratti, M., Lampis, A., Ghidini, M., Salati, M., Mirchev, M. B., Valeri, N., & Hahne, J. C. (2020) · Targeted Oncology · doi:10.1007/s11523-020-00717-x · Cited by 608 · see citing works

Epigenetics and epigenomics in diabetic kidney disease and metabolic memory

Kato, M. V., & Natarajan, R. D. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0135-6 · Cited by 604 · see citing works

Cancer treatments: Past, present, and future

Sonkin, D., Thomas, A., & Teicher, B. A. (2024) · Cancer Genetics · doi:10.1016/j.cancergen.2024.06.002 · Cited by 559 · see citing works

Stem Cell-Derived Exosomes as Nanotherapeutics for Autoimmune and Neurodegenerative Disorders

Riazifar, M., Mohammadi, M. R., Pone, E. J., Yeri, A., Lässer, C., Segaliny, A. I., McIntyre, L. L., Shelke, G. V., Hutchins, E., Hamamoto, A., et al. (2019) · ACS Nano · doi:10.1021/acsnano.9b01004 · Cited by 551 · see citing works

The Promising Role of miR-21 as a Cancer Biomarker and Its Importance in RNA-Based Therapeutics

Bautista-Sánchez, D., Arriaga-Canon, C., Pedroza-Torres, A., De La Rosa-Velázquez, I. A., González-Barrios, R., Contreras-Espinosa, L., Montiel-Manríquez, R., Castro-Hernández, C., Fragoso-Ontiveros, V., Álvarez-Gómez, R. M., et al. (2020) · Molecular Therapy Nucleic Acids · doi:10.1016/j.omtn.2020.03.003 · Cited by 549 · see citing works

Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics

Li, Y., Yu, C. Y., Li, X. X., Zhang, P., Tang, J., Yang, Q., Fu, T., Zhang, X., Cui, X., Tu, G., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1076 · Cited by 523 · see citing works

MicroRNA-34 family: a potential tumor suppressor and therapeutic candidate in cancer

Zhang, L., Liao, Y., & Tang, L. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1059-5 · Cited by 514 · see citing works

Mitochondrial Sirtuin 3: New emerging biological function and therapeutic target

Zhang, J., Xiang, H., Liu, J., Chen, Y., He, R.-R., & Liu, B. (2020) · Theranostics · doi:10.7150/thno.45922 · Cited by 503 · see citing works

Engineered exosomes from different sources for cancer-targeted therapy

Zhang, M. H., Hu, S., Liu, L., Dang, P., Liu, Y., Sun, Z., Qiao, B., & Wang, C. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01382-y · Cited by 487 · see citing works

MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer

Weng, Y.-S., Tseng, H., Chen, Y.-A., Shen, P.-C., Haq, A. T. A., Chen, L.-M., Tung, Y., & Hsu, H.-L. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0988-0 · Cited by 393 · see citing works

Gut Microbiota: An Integral Moderator in Health and Disease

Feng, Q., Chen, W.-D., & Wang, Y.-D. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00151 · Cited by 407 · see citing works

RNAi-based therapeutics and tumor targeted delivery in cancer

Kara, G., Călin, G. A., & Özpolat, B. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114113 · Cited by 417 · see citing works

RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges

Yu, A., Choi, Y. H., & Tu, M. (2020) · Pharmacological Reviews · doi:10.1124/pr.120.019554 · Cited by 405 · see citing works

RNA-Based Therapeutics: From Antisense Oligonucleotides to miRNAs

Bajan, S., & Hutvágner, G. (2020) · Cells · doi:10.3390/cells9010137 · Cited by 399 · see citing works

Trials and Tribulations of MicroRNA Therapeutics

Seyhan, A. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031469 · Cited by 381 · see citing works

TransmiR v2.0: an updated transcription factor-microRNA regulation database

Tong, Z., Cui, Q., Wang, J., & Zhou, Y. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1023 · Cited by 356 · see citing works

Hepatoma cell‐secreted exosomal microRNA‐103 increases vascular permeability and promotes metastasis by targeting junction proteins

Fang, J., Zhang, Z., Shang, L., Luo, Y., Lin, Y., Yuan, Y., & Zhuang, S. (2018) · Hepatology · doi:10.1002/hep.29920 · Cited by 335 · see citing works

Nucleic acid delivery for therapeutic applications

Gupta, A., Andresen, J. L., Manan, R. S., & Langer, R. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113834 · Cited by 339 · see citing works

RNA interference-based therapy and its delivery systems

Chen, X., Mangala, L. S., Rodriguez‐Aguayo, C., Kong, X., Lopez‐Berestein, G., & Sood, A. K. (2017) · Cancer and Metastasis Reviews · doi:10.1007/s10555-017-9717-6 · Cited by 333 · see citing works

Wnt/β-catenin-driven EMT regulation in human cancers

Xue, W., Yang, L., Chen, C., Ashrafizadeh, M., Tian, Y., & Sun, R. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-05099-7 · Cited by 321 · see citing works

Rolling Circular Amplification (RCA)-Assisted CRISPR/Cas9 Cleavage (RACE) for Highly Specific Detection of Multiple Extracellular Vesicle MicroRNAs

Wang, R., Zhao, X., Chen, X., Qiu, X., Qing, G., Zhang, H., Zhang, L., Hu, X., He, Z., Zhong, D., et al. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b04814 · Cited by 315 · see citing works

microRNA-21 promotes breast cancer proliferation and metastasis by targeting LZTFL1

Wang, H., Tan, Z., Hu, H., Liu, H., Wu, T., Zheng, C., Wang, X., Luo, Z., Wang, J., Liu, S., et al. (2019) · BMC Cancer · doi:10.1186/s12885-019-5951-3 · Cited by 304 · see citing works

Ki-67 as a Prognostic Biomarker in Invasive Breast Cancer

Davey, M. G., Hynes, S. O., Kerin, M. J., Miller, N., & Lowery, A. (2021) · Cancers · doi:10.3390/cancers13174455 · Cited by 302 · see citing works

microRNA biosensors: Opportunities and challenges among conventional and commercially available techniques

Kiliç, T., Erdem, A., Özsöz, M., & Carrara, S. (2017) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2017.08.007 · Cited by 298 · see citing works

Herpesvirus latency

Cohen, J. I. (2020) · Journal of Clinical Investigation · doi:10.1172/jci136225 · Cited by 280 · see citing works

The powerful world of antisense oligonucleotides: From bench to bedside

Quéméner, A. M., Bachelot, L., Forestier, A., Donnou‐Fournet, E., Gilot, D., & Galibert, M. (2020) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1594 · Cited by 279 · see citing works

Rational Design of Nanocarriers for Intracellular Protein Delivery

Qin, X., Yu, C., Wei, J., Li, L., Zhang, C., Wu, Q., Liu, J., Yao, S. Q., & Huang, W. (2019) · Advanced Materials · doi:10.1002/adma.201902791 · Cited by 281 · see citing works

Tumor Suppressor miRNA in Cancer Cells and the Tumor Microenvironment: Mechanism of Deregulation and Clinical Implications

Otmani, K., & Lewalle, P. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.708765 · Cited by 287 · see citing works

Reactive oxygen species-based nanomaterials for the treatment of myocardial ischemia reperfusion injuries

Zhao, T., Wu, W., Sui, L., Huang, Q., Nan, Y., Liu, J., & Ai, K. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.06.006 · Cited by 270 · see citing works

Crosstalk between circRNAs and the PI3K/AKT signaling pathway in cancer progression

Xue, C., Li, G., Lü, J., & Li, L. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00788-w · Cited by 264 · see citing works

Circular RNA vaccine in disease prevention and treatment

Niu, D., Wu, Y., & Lian, J. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01561-x · Cited by 273 · see citing works

Noncoding RNAs in cancer therapy resistance and targeted drug development

Wang, W., Han, C., Sun, Y., Chen, T.-Q., & Chen, Y. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0748-z · Cited by 266 · see citing works

RNA demethylase ALKBH5 in cancer: from mechanisms to therapeutic potential

Qu, J., Yan, H., Hou, Y., Cao, W., Liu, Y., Zhang, E., He, J., & Cai, Z. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01224-4 · Cited by 264 · see citing works

Mechanisms of human telomerase reverse transcriptase (hTERT) regulation: clinical impacts in cancer

Leao, R. R. N., Apolónio, J. D., Lee, D., Figueiredo, A., Tabori, U. Y., & Castelo‐Branco, P. (2018) · Journal of Biomedical Science · doi:10.1186/s12929-018-0422-8 · Cited by 266 · see citing works

Preclinical development of a microRNA-based therapy for intervertebral disc degeneration

Ji, M.-L., Jiang, H., Zhang, X.-J., Shi, P., Li, C., Wu, H., Wu, X., Wang, Y., Wang, C., & Lü, J. (2018) · Nature Communications · doi:10.1038/s41467-018-07360-1 · Cited by 259 · see citing works

Therapeutic targeting of angiogenesis molecular pathways in angiogenesis-dependent diseases

Fallah, A., Sadeghinia, A., Kahroba, H., Samadi, A., Heidari, H. R., Bradaran, B., Zeinali, S., & Molavi, O. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.12.022 · Cited by 259 · see citing works

The clinical potential of circulating microRNAs in obesity

Ji, C., & Guo, X. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0260-0 · Cited by 260 · see citing works

MicroRNA-based therapeutics in central nervous system injuries

Sun, P., Liu, D., Jickling, G. C., Sharp, F. R., & Yin, K. (2018) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x18773871 · Cited by 256 · see citing works

Non-coding RNAs in cancer: platforms and strategies for investigating the genomic “dark matter”

Grillone, K., Riillo, C., Scionti, F., Rocca, R., Tradigo, G., Guzzi, P. H., Alcaro, S., Martino, M. T. D., Tagliaferri, P., & Tassone, P. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01622-x · Cited by 253 · see citing works

Noncoding <scp>RNA</scp>s in disease

Lekka, E., & Hall, J. (2018) · FEBS Letters · doi:10.1002/1873-3468.13182 · Cited by 251 · see citing works

Therapeutic targeting of non-coding RNAs in cancer

Slabý, O., Laga, R., & Sedláček, O. (2017) · Biochemical Journal · doi:10.1042/bcj20170079 · Cited by 248 · see citing works

miRPathDB 2.0: a novel release of the miRNA Pathway Dictionary Database

Kehl, T., Kern, F., Backes, C., Fehlmann, T., Stöckel, D., Meese, E. U., Lenhof, H., & Keller, A. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz1022 · Cited by 244 · see citing works

Curcumin Combination Chemotherapy: The Implication and Efficacy in Cancer

Tan, B. L., & Norhaizan, M. E. (2019) · Molecules · doi:10.3390/molecules24142527 · Cited by 246 · see citing works

Challenges identifying efficacious miRNA therapeutics for cancer

Segal, M., & Slack, F. J. (2020) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2020.1765770 · Cited by 244 · see citing works

MicroRNAs and metastasis: small RNAs play big roles

Kim, J., Yao, F., Xiao, Z., Sun, Y., & Ma, L. (2017) · Cancer and Metastasis Reviews · doi:10.1007/s10555-017-9712-y · Cited by 236 · see citing works

MicroRNAs in Neuroinflammation: Implications in Disease Pathogenesis, Biomarker Discovery and Therapeutic Applications

Slota, J. A., & Booth, S. A. (2019) · Non-Coding RNA · doi:10.3390/ncrna5020035 · Cited by 233 · see citing works

DNAzyme-Mediated Assays for Amplified Detection of Nucleic Acids and Proteins

Peng, H., Newbigging, A. M., Wang, Z., Tao, J., Deng, W., Le, X. C., & Zhang, H. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b04926 · Cited by 229 · see citing works

MicroRNA-155—at the Critical Interface of Innate and Adaptive Immunity in Arthritis

Alivernini, S., Gremese, E., McSharry, C. P., Tolusso, B., Ferraccioli, G., McInnes, I. B., & Kurowska‐Stolarska, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01932 · Cited by 226 · see citing works

A Comprehensive Review of Cancer MicroRNA Therapeutic Delivery Strategies

Forterre, A. V., Komuro, H., Aminova, S., & Harada, M. (2020) · Cancers · doi:10.3390/cancers12071852 · Cited by 228 · see citing works

Role of microRNAs in obesity and obesity-related diseases

Iacomino, G., & Siani, A. (2017) · Genes & Nutrition · doi:10.1186/s12263-017-0577-z · Cited by 225 · see citing works

Pyroptosis and ferroptosis induced by mixed lineage kinase 3 (MLK3) signaling in cardiomyocytes are essential for myocardial fibrosis in response to pressure overload

Wang, J., Deng, B., Liu, Q., Huang, Y., Chen, W., Li, J., Zhou, Z., Zhang, L., Liang, B., He, J., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02777-3 · Cited by 223 · see citing works

Human Breast Milk Composition and Function in Human Health: From Nutritional Components to Microbiome and MicroRNAs

Yi, D. Y., & Kim, S. (2021) · Nutrients · doi:10.3390/nu13093094 · Cited by 225 · see citing works

Tumor Cell-Derived Extracellular Vesicle-Coated Nanocarriers: An Efficient Theranostic Platform for the Cancer-Specific Delivery of Anti-miR-21 and Imaging Agents

Bose, R. J., Sukumar, U. K., Zeng, Y., Afjei, R., Robinson, E. R., Lau, K. H., Bermudez, A., Habte, F. G., Pitteri, S. J., Sinclair, R., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b02587 · Cited by 224 · see citing works

mTORC1 as a Regulator of Mitochondrial Functions and a Therapeutic Target in Cancer

de la Cruz-López, K. G., Toledo-Guzmán, M. E., Sánchez, E. O., & Carrancá, A. G. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01373 · Cited by 215 · see citing works

Gene Therapy in Cancer Treatment: Why Go Nano?

Roma‐Rodrigues, C., Rivas‐García, L., Baptista, P. V., & Fernandes, A. R. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12030233 · Cited by 221 · see citing works

Paving the Road for RNA Therapeutics

Dammes, N., & Peer, D. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.08.004 · Cited by 220 · see citing works

microRNAs in Parkinson’s Disease: From Pathogenesis to Novel Diagnostic and Therapeutic Approaches

Leggio, L., Vivarelli, S., L’Episcopo, F., Tirolo, C., Caniglia, S., Testa, N., Marchetti, B., & Iraci, N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122698 · Cited by 216 · see citing works

The Risks of miRNA Therapeutics: In a Drug Target Perspective

Zhang, S., Cheng, Z., Wang, Y., & Han, T. (2021) · Drug Design Development and Therapy · doi:10.2147/dddt.s288859 · Cited by 216 · see citing works

Tetramethylpyrazine: A review on its mechanisms and functions

Lin, J., Wang, Q., Zhou, S., Xu, S., & Yao, K. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113005 · Cited by 217 · see citing works

MicroRNA in cancer therapy: breakthroughs and challenges in early clinical applications

Martino, M. T. D., Tagliaferri, P., & Tassone, P. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03391-x · Cited by 228 · see citing works

MiRNA-210: A Current Overview

Bavelloni, A., Ramazzotti, G., Poli, A., Piazzi, M., Focaccia, E., Blalock, W. L., & Faenza, I. (2017) · Anticancer Research · doi:10.21873/anticanres.12107 · Cited by 210 · see citing works

MicroRNA Therapeutics in Cancer: Current Advances and Challenges

Sayed, S. R. E., Cristante, J., Guyon, L., Denis, J., Chabre, O., & Cherradi, N. (2021) · Cancers · doi:10.3390/cancers13112680 · Cited by 211 · see citing works

Roadmap and strategy for overcoming infusion reactions to nanomedicines

Szebeni, J., Simberg, D., González‐Fernández, Á., Barenholz, Y., & Dobrovolskaia, M. A. (2018) · Nature Nanotechnology · doi:10.1038/s41565-018-0273-1 · Cited by 206 · see citing works

How does hip osteoarthritis differ from knee osteoarthritis?

Hall, M., van der Esch, M., Hinman, R. S., Peat, G., de Zwart, A. H., Quicke, J. G., Runhaar, J., Knoop, J., van der Leeden, M., de Rooij, M., et al. (2021) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2021.09.010 · Cited by 210 · see citing works

Non-coding RNAs in cardiovascular cell biology and atherosclerosis

Fasolo, F., Gregoli, K. D., Mäegdefessel, L., & Johnson, J. L. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz203 · Cited by 202 · see citing works

circNFIB1 inhibits lymphangiogenesis and lymphatic metastasis via the miR-486-5p/PIK3R1/VEGF-C axis in pancreatic cancer

Kong, Y., Li, Y., Luo, Y., Zhu, J., Zheng, H., Gao, B., Guo, X., Li, Z., Chen, R., & Chen, C. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01205-6 · Cited by 201 · see citing works

Circulating miRNA analysis for cancer diagnostics and therapy

Valihrach, L., Androvic, P., & Kubista, M. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.10.002 · Cited by 199 · see citing works

MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside

To, K. K. W., Tong, C. W. S., Wu, M., & Cho, W. C. S. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i27.2949 · Cited by 195 · see citing works

Classical and noncanonical functions of miRNAs in cancers

Dragomir, M. P., Knutsen, E., & Călin, G. A. (2021) · Trends in Genetics · doi:10.1016/j.tig.2021.10.002 · Cited by 194 · see citing works

Discovery and preclinical evaluation of anti-miR-17 oligonucleotide RGLS4326 for the treatment of polycystic kidney disease

Lee, E. C. Y., Valencia, T., Allerson, C. R., Schairer, A., Flaten, A., Yheskel, M., Kersjes, K., Li, J., Gatto, S., Takhar, M. M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11918-y · Cited by 193 · see citing works

A guide to miRNAs in inflammation and innate immune responses

Nejad, C., Stunden, H. J., & Gantier, M. P. (2018) · FEBS Journal · doi:10.1111/febs.14482 · Cited by 192 · see citing works

Recent Advances in Oligonucleotide Therapeutics in Oncology

Xiong, H., Veedu, R. N., & Diermeier, S. D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073295 · Cited by 187 · see citing works

Microbial dysbiosis in the gut drives systemic autoimmune diseases

Mousa, W. K., Chehadeh, F., & Husband, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.906258 · Cited by 207 · see citing works

Circulating Exosomal miR‐20b‐5p Inhibition Restores Wnt9b Signaling and Reverses Diabetes‐Associated Impaired Wound Healing

Xiong, Y., Chen, L., Yan, C., Zhou, W., Endo, Y., Liu, J., Hu, L., Hu, Y., Mi, B., & Liu, G. (2019) · Small · doi:10.1002/smll.201904044 · Cited by 185 · see citing works

Novel quinazoline-based EGFR kinase inhibitors: A review focussing on SAR and molecular docking studies (2015-2019)

Bhatia, P., Sharma, V., Alam, O., Manaithiya, A., Alam, P., Kahksha, Alam, M. T., & Imran, M. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112640 · Cited by 183 · see citing works

The role of microRNAs in neurodegenerative diseases: a review

Li, S., Lei, Z., & Sun, T. (2022) · Cell Biology and Toxicology · doi:10.1007/s10565-022-09761-x · Cited by 192 · see citing works

miRNAs reshape immunity and inflammatory responses in bacterial infection

Zhou, X., Li, X., & Wu, M. (2018) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-018-0006-9 · Cited by 183 · see citing works

MicroRNAs as modulators of longevity and the aging process

Kinser, H. E., & Pincus, Z. (2019) · Human Genetics · doi:10.1007/s00439-019-02046-0 · Cited by 182 · see citing works

The Roles of the Let-7 Family of MicroRNAs in the Regulation of Cancer Stemness

Ma, Y., Shen, N., Wicha, M. S., & Luo, M. (2021) · Cells · doi:10.3390/cells10092415 · Cited by 183 · see citing works

miR-196b-5p–mediated downregulation of TSPAN12 and GATA6 promotes tumor progression in non-small cell lung cancer

Liang, G., Meng, W., Huang, X., Zhu, W., Yin, C., Wang, C., Fassan, M., Yu, Y., Kudo, M., Xiao, S., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1917531117 · Cited by 180 · see citing works

Chemically Modified Platforms for Better RNA Therapeutics

Shi, Y., Zhen, X., Zhang, Y., Li, Y., Koo, S., Saiding, Q., Kong, N., Liu, G., Chen, W., & Tao, W. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00611 · Cited by 184 · see citing works

Deep-belief network for predicting potential miRNA-disease associations

Chen, X., Li, T., Zhao, Y. F., Wang, C.-C., & Zhu, C.-C. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa186 · Cited by 178 · see citing works

MicroRNA replacement therapy in cancer

Mollaei, H., Safaralizadeh, R., & Rostami, Z. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28058 · Cited by 262 · see citing works

The Therapeutic Potential of MicroRNAs in Cancer

Thorsen, S. B., Obad, S., Jensen, N. F., Stenvang, J., & Kauppinen, S. (2012) · The Cancer Journal · doi:10.1097/ppo.0b013e318258b5d6 · Cited by 116 · see citing works

Targeting miRNAs and Other Non-Coding RNAs as a Therapeutic Approach: An Update

Bayraktar, E., Bayraktar, R., Öztatlıcı, H., Lopez‐Berestein, G., Amero, P., & Rodriguez‐Aguayo, C. (2023) · Non-Coding RNA · doi:10.3390/ncrna9020027 · Cited by 86 · see citing works

Advances in the discovery of microRNA-based anticancer therapeutics: latest tools and developments

To, K. K. W., Fong, W., Tong, C. W. S., Wu, M., Yan, W., & Cho, W. C. S. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2020.1690449 · Cited by 57 · see citing works

MicroRNA as an Important Target for Anticancer Drug Development

Fu, Z., Wang, L., Li, S., Chen, F., Au-Yeung, K. K.-W., & Shi, C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.736323 · Cited by 133 · see citing works